CRyo-Ablation to Treat Patients With HOCM. (CRASH)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01875016|
Recruitment Status : Unknown
Verified June 2013 by MEDINA AHARON, Shaare Zedek Medical Center.
Recruitment status was: Not yet recruiting
First Posted : June 11, 2013
Last Update Posted : June 11, 2013
Shaare Zedek Medical Center
Information provided by (Responsible Party):
MEDINA AHARON, Shaare Zedek Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||April 2015|
Keane D, Hynes B, King G, Shiels P, Brown A. Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy. J Invasive Cardiol. 2007 Jun;19(6):247-51.
Lawrenz T, Borchert B, Leuner C, Bartelsmeier M, Reinhardt J, Strunk-Mueller C, Meyer Zu Vilsendorf D, Schloesser M, Beer G, Lieder F, Stellbrink C, Kuhn H. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. J Am Coll Cardiol. 2011 Feb 1;57(5):572-6. doi: 10.1016/j.jacc.2010.07.055.